Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $6.32, denoting a -3.36% move from the preceding trading day.

Tilray Brands, Inc. (TLRY) reached $6.54 at the closing of the latest trading day, reflecting a -5.76% change compared to its last close.

Iconic Popsicle® Flavors Reimagined as Ready-to-Drink Hard Beverages Through New Licensing Agreement NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, is teaming up with The Magnum Ice Cream Company , the world's largest ice cream company, to give an adult upgrade to a beloved classic. Today, Tilray is announcing its line of exclusive Popsicle® Hard flavored ready-to-drink beverages, inspired by the iconic flavors Popsicle fans grew up with to bring a nostalgic favorite into a new format for 21+ consumers in the U.S. By pairing Tilray's beverage innovation expertise with Popsicle's beloved legacy and fanbase, Tilray has set out to capture the taste and joy of Popsicle with an added 5% ABV kick, available in non-carbonated Hard Cherry, Hard Orange and Hard Grape.

NEW YORK and LEAMINGTON, Ontario, March 25, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the third fiscal quarter which ended February 28, 2026, before the financial markets open on Wednesday, April 1, 2026.

irwin Simon recently snatched up UK-based BrewDog for a cool $53 million – a far cry from the $2 billion valuation it had at its peak.

Tilray stock price has plummeted and lost crucial support as demand for cannabis companies wanes. TLRY dropped to $6.7 on Wednesday, its lowest level since August last year.

NEW YORK and SYDNEY, March 19, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), today announced its largest portfolio expansion in Australia to date. The expanded medical cannabis offering reinforces Tilray Medical's long-term commitment to the Australian market and supports increased patient access to regulated, clinically supported medical cannabis products.